En este trabajo se pretende evaluar la inmunogenicidad de la vacuna BNT162b2 (Pfizer/BioNTech), evaluando la capacidad neutralizante de los anticuerpos producidos contra el SARS-CoV-2 en población colombiana sin historia de infección por COVID-19 al momento de ingresar al estudio. Con los resultados esperados pretendemos arrojar datos reales que permitan estimar la efectividad de dicha vacuna en la neutralización del virus wild type y las variantes de preocupación (VOC) alfa (B.1.1.7, identificada en Reino Unido) y gamma (P.1, identificada en Brasil)
Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

There are no dataverses within this dataverse. Please log in to see if you are able to add to it.

Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.